These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 73397)

  • 1. Serum dihydrotestosterone in patients with benign prostatic hypertrophy.
    Ghanadian R; Lewis JG; Chisholm GD; O'Donoghue EP
    Br J Urol; 1977 Nov; 49(6):541-4. PubMed ID: 73397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total and SHBG-bound testosterone and 5 alpha-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma.
    Lukkarinen O
    Br J Urol; 1980 Oct; 52(5):377-80. PubMed ID: 6159037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma steroids in benign prostatic hypertrophy and carcinoma of the prostate.
    Drafta D; Proca E; Zamfir V; Schindler AE; Neacşu E; Stroe E
    J Steroid Biochem; 1982 Dec; 17(6):689-93. PubMed ID: 6184548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responses of serum levels of testicular steroid hormones to hCG stimulation in patients with prostatic cancer and benign prostatic hypertrophy.
    Isurugi K; Kanazawa M; Yanaihara T; Kambegawa A
    Prostate Suppl; 1981; 1():19-26. PubMed ID: 6176980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL.
    Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y
    Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of 3H-testosterone and 3H-dihydrotestosterone metabolism in patients with benign prostatic hypertrophy. Effect of cyproterone acetate.
    Hutschenreiter G; Sinterhauf K; Altwein JE
    Eur Urol; 1977; 3(2):100-4. PubMed ID: 67948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive effects of surgical stress on circulating androgens during and after prostatectomy.
    Ghanadian R; Puah CM; Williams G; Shah PJ; McWhinney N
    Br J Urol; 1981 Apr; 53(2):147-9. PubMed ID: 6165423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum testosterone and dihydrotestosterone in carcinoma of the prostate.
    Ghanadian R; Puah CM; O'Donoghue EP
    Br J Cancer; 1979 Jun; 39(6):696-9. PubMed ID: 444409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of serum dihydrotestosterone and subsequent risk of benign prostatic hyperplasia in community dwelling men: the Rancho Bernardo Study.
    Parsons JK; Palazzi-Churas K; Bergstrom J; Barrett-Connor E
    J Urol; 2010 Sep; 184(3):1040-4. PubMed ID: 20643424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer.
    Rittmaster R; Hahn RG; Ray P; Shannon JB; Wurzel R
    Urology; 2008 Oct; 72(4):808-12. PubMed ID: 18718641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of T and DHT contents in normal and diseased human prostate tissues].
    Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D
    Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurements of prolactin and androgens in patients with prostatic diseases.
    Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP
    Oncology; 1980; 37(1):46-52. PubMed ID: 6153126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone.
    Addo SB; Holland JF; Kirschenbaum A; Mandeli J; Hollander VP
    Steroids; 1990 Nov; 55(11):491-4. PubMed ID: 1706116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
    Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
    Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of dihydrotestosterone by human prostate in benign prostatic hypertrophy.
    Mahoudeau JA; Delassalle A; Bricaire H
    Acta Endocrinol (Copenh); 1974 Oct; 77(2):401-7. PubMed ID: 4138446
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia.
    Wurzel R; Ray P; Major-Walker K; Shannon J; Rittmaster R
    Prostate Cancer Prostatic Dis; 2007; 10(2):149-54. PubMed ID: 17189955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen levels in the plasma and prostatic tissues of patients with benign hypertrophy and carcinoma of the prostate.
    Habib FK; Lee IR; Stitch SR; Smith PH
    J Endocrinol; 1976 Oct; 71(1):99-107. PubMed ID: 62008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years.
    Liao CH; Li HY; Chung SD; Chiang HS; Yu HJ
    Aging Male; 2012 Mar; 15(1):28-33. PubMed ID: 21247242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of spironolactone on the concentration of gonadotrophins and gonadal hormones in prostatic hypertrophy (author's transl)].
    Zgliczynski S; Baranowska B; Szymanowski J
    J Urol (Paris); 1981; 87(9):635-8. PubMed ID: 6174646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.